The Genomics of Liposarcoma a Review and Commentary
Abstract
Abstract not found
Downloads
- Article PDF
- LaTeX Kaleidoscope* (Beta by AI)
- TEI XML Kaleidoscope (download in zip)* (Beta by AI)
- Lens* NISO JATS XML (Beta by AI)
- HTML Kaleidoscope* (Beta by AI)
- DBK XML Kaleidoscope (download in zip)* (Beta by AI)
- LaTeX pdf Kaleidoscope* (Beta by AI)
- EPUB Kaleidoscope* (Beta by AI)
- MD Kaleidoscope* (Beta by AI)
- FO Kaleidoscope* (Beta by AI)
- BIB Kaleidoscope* (Beta by AI)
How to Cite
References
Taylor (2011) Advances in sarcoma genomics and new therapeutic targets. 11(8), 541-557. https://doi.org/10.1038/nrc3087
Stanelle, survival pediatric (2012) Prognostic Factors and Survival in Pediatric and Adolescent Liposarcoma. 2012, 1-6. https://doi.org/10.1155/2012/870910
Oh (2016) Prognostic Model to Predict Survival Outcome for Curatively Resected Liposarcoma: A Multi-Institutional Experience. 7(9), 1174-1180. https://doi.org/10.7150/jca.15243
Knebel, C. factors (2017) Prognostic factors and outcome of Liposarcoma patients: a retrospective evaluation over 15 years. 17(1), 410. https://doi.org/10.1186/s12885-017-3398-y
S. Schwartz, S. Centurion (2019)
Alaggio (2009) Liposarcomas in Young Patients. 33(5), 645-658. https://doi.org/10.1097/pas.0b013e3181963c9c
Sinclair (2017) Pleomorphic myxoid liposarcoma in an adolescent with Li-Fraumeni syndrome. 33(5), 631-635. https://doi.org/10.1007/s00383-017-4063-x
(2017) Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. 171, 950-965. https://doi.org/10.1016/j.cell.2017.10.014
C. Antonescu (2006) The role of genetic testing in soft tissue sarcoma. 48(1), 13-21. https://doi.org/10.1111/j.1365-2559.2005.02285.x
E. Borden Soft tissue sarcomas of adults: state of the translational science. 9.
Eischen (2016) Genome Stability Requires p53. a026096. https://doi.org/10.1101/cshperspect.a026096
Ghadimi (2011) Pleomorphic liposarcoma. 117(23), 5359-5369. https://doi.org/10.1002/cncr.26195
Kanojia (2015) Genomic landscape of liposarcoma. 6(40), 2429-4244. https://doi.org/10.18632/oncotarget.6464
Wang (2011) High Fat Diet Induces Formation of Spontaneous Liposarcoma in Mouse Adipose Tissue with Overexpression of Interleukin 22. 6(8), e23737. https://doi.org/10.1371/journal.pone.0023737
Uri Ben-David, Angelika Amon (2020) Context is everything: aneuploidy in cancer. 21(1), 44-62. https://doi.org/10.1038/s41576-019-0171-x
Singer, potential well-differentiated (2007) Gene Expression Profiling of Liposarcoma Identifies Distinct Biological Types/Subtypes and Potential Therapeutic Targets in Well-Differentiated and Dedifferentiated Liposarcoma. 67(14), 6626-6636. https://doi.org/10.1158/0008-5472.can-07-0584
Matushansky (2008) A Developmental Model of Sarcomagenesis Defines a Differentiation-Based Classification for Liposarcomas. 172(4), 1069-1080. https://doi.org/10.2353/ajpath.2008.070284
H. Yu, D. Pei, L. Chen, X. Zhou, H. Zhu Zhu, H Identification of key genes and molecular mechanisms associated with dedifferentiated liposarcoma based on bioinformatic methods. 10, 3017-3027. https://doi.org/10.2147/OTT.S1
R. Kleinerman, S. Schonfeld, Tucker (2012) Sarcomas in hereditary retinoblastoma. 2, 15. https://doi.org/10.1186/2045-3329-2-15
F. Li (1988) A cancer family syndrome in twentyfour kindreds. 48, 5358-5362.
P. Kleihues, B. Schauble, A. zur Hausen, J. Esteve, H. Ohgaki (1997) Tumors associated with p53 germline mutations: a synopsis of 91 families. 150, 1-13.
Liu, G. stability, in apoptosis (2004) Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice. 36(1), 63-68. https://doi.org/10.1038/ng1282
Harvey (1995) A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53-deficient mice. 9(3), 305-311. https://doi.org/10.1038/ng0395-305
Aaron McCoy, Cynthia Besch-Williford, Craig Franklin, Edward Weinstein, Xiaoxia Cui (2013) Creation and preliminary characterization of a Tp53 knockout rat. 6, 269-278. https://doi.org/10.1242/dmm.009704
Hermsen (2015) Lack of Major Genome Instability in Tumors of p53 Null Rats. 10(3), e0122066. https://doi.org/10.1371/journal.pone.0122066
Van Boxtel, R. Homozygous (2011) Homozygous and Heterozygous p53 Knockout Rats Develop Metastasizing Sarcomas with High Frequency. 179(4), 1616-1622. https://doi.org/10.1016/j.ajpath.2011.06.036
M. Harvey, H. Vogel, E. Lee, A. Bradley, L. Donehower (1995) Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin. 55, 1146-1151.
Puzio-Kuter (2015) Involvement of tumor suppressors PTEN and p53 in the formation of multiple subtypes of liposarcoma. 22(11), 1785-1791. https://doi.org/10.1038/cdd.2015.27
M. Guijarro (2013) Dual Pten/Tp53 suppression promotes sarcoma progression by activating Notch signaling. 182. https://doi.org/10.1016/j.ajpath.2013.02.035
Kim (2016) Prognostic implications ofPIK3CAamplification in curatively resected liposarcoma. 7(17), 4549-2455. https://doi.org/10.18632/oncotarget.8240
Beird (2018) Genomic profiling of dedifferentiated liposarcoma compared to matched well-differentiated liposarcoma reveals higher genomic complexity and a common origin. a002386. https://doi.org/10.1101/mcs.a002386
S. Boregowda V et al Basal p53 expression is indispensable for mesenchymal stem cell integrity. 25, 679-692. https://doi.org/10.1038/s41418-
Julien Sage (2012) The retinoblastoma tumor suppressor and stem cell biology. 26(13), 1409-1420. https://doi.org/10.1101/gad.193730.112
Velletri (2020) Loss of p53 in mesenchymal stem cells promotes alteration of bone remodeling through negative regulation of osteoprotegerin. https://doi.org/10.1038/s41418-020-0590-4
O. Calvete et al The wide spectrum of POT1 gene variants correlates with multiple cancer types. 25, 1278-1281. https://doi.org/10.1038/ejhg
Hirata (2006) A Novel Germline Mutation of MSH2 in a Hereditary Nonpolyposis Colorectal Cancer Patient with Liposarcoma. 101(1), 193-196. https://doi.org/10.1111/j.1572-0241.2005.00308.x
Yozu (2013) Muir-Torre syndrome-associated pleomorphic liposarcoma arising in a previous radiation field. 462(3), 355-360. https://doi.org/10.1007/s00428-012-1369-x
Kelly Butnor, Elizabeth Pavlisko, Thomas Sporn, Victor Roggli (2018) Malignant Mesothelioma in Individuals With Nonmesothelial Neoplasms. 142(6), 730-734. https://doi.org/10.5858/arpa.2017-0307-oa
M. Ferreira (2018) Presence of TERT Promoter Mutations is a Secondary Event and Associates with Elongated Telomere Length in Myxoid Liposarcomas. https://doi.org/10.3390/ijms19020608
J. Lee C et al Alternative lengthening of telomeres and loss of ATRX are frequent events in pleomorphic and dedifferentiated liposarcomas. 28, 1064-1073. https://doi.org/10.1038/modpathol
L. Venturini, R. Motta, A. Gronchi, M. Daidone, N. Zaffaroni Venturini, L., Motta, R., Gronchi, A., Daidone, M. & Zaffaroni, N. Prognostic relevance of ALTassociated markers in liposarcoma: a comparative analysis. 10, 254. https://doi.org/10.1186/1471-
R. Lawlor Lawlor, R. T. et al. Alternative lengthening of telomeres (ALT) influences survival in soft tissue sarcomas: a systematic review with meta-analysis. 19, 232. https://doi.org/10.1186/s12885-019-
Xiaolei Ren, Chao Tu, Zhenchu Tang, Ruofei Ma, Zhihong Li (2018) Alternative lengthening of telomeres phenotype and loss of ATRX expression in sarcomas (Review). 15, 7489-7496. https://doi.org/10.3892/ol.2018.8318
(2006) Telomere Maintenance Mechanisms in Liposarcomas: Association with Histologic Subtypes and Disease Progression. 66(17), 8918-8924. https://doi.org/10.1158/0008-5472.can-06-0273
Toro, regardless site, in surveillance, epidemiology, end results program (2006) An analysis of 26,758 cases. 119(12), 2922-2930. https://doi.org/10.1002/ijc.22239
K. Baird Gene expression profiling of human sarcomas: insights into sarcoma biology. 65, 9226-9235. https://doi.org/10.1158/0008-5472.CAN-
Gisselsson (2001) PLAG1 Alterations in Lipoblastoma. 159(3), 955-962. https://doi.org/10.1016/s0002-9440(10)61771-3
K. Mrozek, C. Karakousis, C. Bloomfield Chromosome 12 breakpoints are cytogenetically different in benign and malignant lipogenic tumors: localization of breakpoints in lipoma to 12q15 and in myxoid liposarcoma to 12q13.3. 53.
D. Kanojia Identification of somatic alterations in lipoma using whole exome sequencing.
Amin-Mansour (2019) Genomic Evolutionary Patterns of Leiomyosarcoma and Liposarcoma. 25(16), 5135-5142. https://doi.org/10.1158/1078-0432.ccr-19-0271
J. Rosai Combined morphologic and karyotypic study of 59 atypical lipomatous tumors. Evaluation of their relationship and differential diagnosis with other adipose tissue tumors (a report of the CHAMP Study Group). 20.
Garsed (2014) The Architecture and Evolution of Cancer Neochromosomes. 26(5), 653-667. https://doi.org/10.1016/j.ccell.2014.09.010
Rieker (2010) Genomic profiling reveals subsets of dedifferentiated liposarcoma to follow separate molecular pathways. 456(3), 277-285. https://doi.org/10.1007/s00428-009-0869-9
Dei Tos (2000) Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours. 190(5), 531-536.
F. Pedeutour (1999) Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors. 24, 30-41.
M. Koczkowska Koczkowska, M. et al. Application of high-resolution genomic profiling in the differential diagnosis of liposarcoma. 10, 7. https://doi.org/10.1186/s
Erickson-Johnson (2009) Carboxypeptidase M: a biomarker for the discrimination of well-differentiated liposarcoma from lipoma. 22(12), 1541-1547. https://doi.org/10.1038/modpathol.2009.149
Wang, formation (2021) Extrachromosomal Circular DNAs: Origin, formation and emerging function in Cancer. 17(4), 1010-1025. https://doi.org/10.7150/ijbs.54614
B. Taylor S et al Frequent alterations and epigenetic silencing of differentiation pathway genes in structurally rearranged liposarcomas. 1, 587-597. https://doi.org/10.1158/2159-8290.CD-11-
Kim (2020) Extrachromosomal DNA is associated with oncogene amplification and poor outcome across multiple cancers. 52(9), 891-897. https://doi.org/10.1038/s41588-020-0678-2
Yi (2022) Live-Cell Imaging Shows Uneven Segregation of Extrachromosomal DNA Elements and Transcriptionally Active Extrachromosomal DNA Hubs in Cancer. 12(2), 468-483. https://doi.org/10.1158/2159-8290.cd-21-1376
Zhang, Y. Heterogeneity (2013) Heterogeneity and immunophenotypic plasticity of malignant cells in human liposarcomas. 11(2), 772-781. https://doi.org/10.1016/j.scr.2013.04.011
Tyler (2020) A review of retroperitoneal liposarcoma genomics. 86, 102013. https://doi.org/10.1016/j.ctrv.2020.102013
P. Hallenborg (2012) Mdm2 controls CREBdependent transactivation and initiation of adipocyte differentiation. 19(8), 1381-1389. https://doi.org/10.1038/cdd.2012.15
Zhao (2022) Murine double minute 2 aggravates adipose tissue dysfunction through ubiquitin-mediated six-transmembrane epithelial antigen of prostate 4 degradation. 25(7), 104544. https://doi.org/10.1016/j.isci.2022.104544
Zhao‐jun Liu, Ying Zhuge, Omaida Velazquez (2009) Trafficking and differentiation of mesenchymal stem cells. 106(6), 984-991. https://doi.org/10.1002/jcb.22091
Melvin Ambele, Carla Dessels, Chrisna Durandt, Michael Pepper (2016) Genome-wide analysis of gene expression during adipogenesis in human adipose-derived stromal cells reveals novel patterns of gene expression during adipocyte differentiation. 16(3), 725-734. https://doi.org/10.1016/j.scr.2016.04.011
Meyers (2017) Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells. 49(12), 1779-1784. https://doi.org/10.1038/ng.3984
J. Dempster Extracting Biological Insights from the Project Achilles Genome-Scale CRISPR Screens in Cancer Cell Lines. 720243.
Engstrom (2006) The myxoid/round cell liposarcoma fusion oncogene FUS-DDIT3 and the normal DDIT3 induce a liposarcoma phenotype in transfected human fibrosarcoma cells. 168, 1642-1653. https://doi.org/10.2353/ajpath.2006.050872
C. Kabjorn Gustafsson, K. Engstrom, Aman (2014) DDIT3 Expression in Liposarcoma Development. 2014. https://doi.org/10.1155/2014/954671
N. Batchvarova, X. Wang, D. Ron (1995) Inhibition of adipogenesis by the stress-induced protein CHOP (Gadd153). 14, 4654-4661.
Yoon Lim, Boon Low, Jormay Lim, Esther Wong, Graeme Guy (1999) Association of Atypical Protein Kinase C Isotypes with the Docker Protein FRS2 in Fibroblast Growth Factor Signaling. 274(27), 9025-1903. https://doi.org/10.1074/jbc.274.27.19025
Kahkonen (2018) Role of fibroblast growth factor receptors (FGFR) and FGFR like-1 (FGFRL1) in mesenchymal stromal cell differentiation to osteoblasts and adipocytes. 461, 194-204. https://doi.org/10.1016/j.mce.2017.09.015
Nayan Patel, Sudhesh Kumar, Margaret Eggo (2005) Essential Role of Fibroblast Growth Factor Signaling in Preadipoctye Differentiation. 90(2), 1226-1232. https://doi.org/10.1210/jc.2004-1309
Hutley (2004) Fibroblast Growth Factor 1. 53(12), 3097-3106. https://doi.org/10.2337/diabetes.53.12.3097
Le Blanc, S. Simann, M. Jakob, F. Schutze, N. Schilling, T. (2015) Fibroblast growth factors 1 and 2 inhibit adipogenesis of human bone marrow stromal cells in 3D collagen gels. 338, 136-148. https://doi.org/10.1016/j.yexcr.2015.09.009
P. Rogalla HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors. 149.
Gilka Gattas, Bradley Quade, Romana Nowak, Cynthia Morton (1999) HMGIC expression in human adult and fetal tissues and in uterine leiomyomata. 25(4), 316-322. https://doi.org/10.1002/(sici)1098-2264(199908)25:4
Xi (2016) HMGA2 promotes adipogenesis by activating C/EBPβ-mediated expression of PPARγ. 472(4), 617-623. https://doi.org/10.1016/j.bbrc.2016.03.015
Thies (2014) Permanent activation of HMGA2 in lipomas mimics its temporal physiological activation linked to the gain of adipose tissue. 22(1), 141-150. https://doi.org/10.1002/oby.20137
Fedele (2006) HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity. 9(6), 459-471. https://doi.org/10.1016/j.ccr.2006.04.024
S. Battista (1999) The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis. 59, 4793-4797.
Ligon (2005) Constitutional Rearrangement of the Architectural Factor HMGA2: A Novel Human Phenotype Including Overgrowth and Lipomas. 76(2), 340-348. https://doi.org/10.1086/427565
H. Jung (2009) et al Involvement of PTP-RQ in differentiation during adipogenesis of human mesenchymal stem cells. 383, 252-257. https://doi.org/10.1016/j.bbrc.2009
Jeong Park, Robert Roeder (2006) GAS41 Is Required for Repression of the p53 Tumor Suppressor Pathway during Normal Cellular Proliferation. 26(11), 4006-4016. https://doi.org/10.1128/mcb.02185-05
Pikor (2013) YEATS4 Is a Novel Oncogene Amplified in Non-Small Cell Lung Cancer That Regulates the p53 Pathway. 73(24), 7301-7312. https://doi.org/10.1158/0008-5472.can-13-1897
A. Crago Copy number losses define subgroups of dedifferentiated liposarcoma with poor prognosis and genomic instability. 18, 1334-1340. https://doi.org/10.1158/1078-0432.CCR-
Mariani (2007) JUN Oncogene Amplification and Overexpression Block Adipocytic Differentiation in Highly Aggressive Sarcomas. 11(4), 361-374. https://doi.org/10.1016/j.ccr.2007.02.007
Fullenkamp, C. TAZ (2016) TAZ and YAP are frequently activated oncoproteins in sarcomas. 7(21), 0094-3010. https://doi.org/10.18632/oncotarget.8979
Seo (2013) SOX2 Regulates YAP1 to Maintain Stemness and Determine Cell Fate in the Osteo-Adipo Lineage. 3(6). https://doi.org/10.1016/j.celrep.2013.05.029
Egan (2014) Whole Genome Analyses of a Well-Differentiated Liposarcoma Reveals Novel SYT1 and DDR2 Rearrangements. 9(2), e87113. https://doi.org/10.1371/journal.pone.0087113
Tap (2011) Evaluation of well‐differentiated/de‐differentiated liposarcomas by high‐resolution oligonucleotide array‐based comparative genomic hybridization. 50(2), 95-112. https://doi.org/10.1002/gcc.20835
C. Fletcher, J. Bridge, P. Hogendoorn, F. Mertens (2013) WHO Classification of Tumours of Soft Tissue and Bone.
H. Cheng (2009) et al Validation of immature adipogenic status and identification of prognostic biomarkers in myxoid liposarcoma using tissue microarrays. 40, 1244-1251. https://doi.org/10.1016/j.humpath.2009
T. Smith, K. Easley, J. Goldblum (1996) Myxoid/round cell liposarcoma of the extremities. A clinicopathologic study of 29 cases with particular attention to extent of round cell liposarcoma. 20, 171-180.
Fritchie (2012) The expanded histologic spectrum of myxoid liposarcoma with an emphasis on newly described patterns: implications for diagnosis on small biopsy specimens. 137, 229-239.
P. Aman Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(q13;p11). 5.
Powers (2010) Detection of myxoid liposarcoma-associated FUS-DDIT3 rearrangement variants including a newly identified breakpoint using an optimized RT-PCR assay. 23(10), 1307-1315. https://doi.org/10.1038/modpathol.2010.118
Anne Crozat, Pierre Åman, Nils Mandahl, David Ron (1993) Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. 363(6430), 640-644. https://doi.org/10.1038/363640a0
Riggi (2006) Expression of the FUS-CHOP Fusion Protein in Primary Mesenchymal Progenitor Cells Gives Rise to a Model of Myxoid Liposarcoma. 66(14), 7016-7023. https://doi.org/10.1158/0008-5472.can-05-3979
Perez-Mancera, C/EBPalpha (2008) FUS-DDIT3 Prevents the Development of Adipocytic Precursors in Liposarcoma by Repressing PPARγ and C/EBPα and Activating eIF4E. 3, e2569. https://doi.org/10.1371/journal.pone.0002569
Trautmann (2017) FUS-DDIT3 Fusion Protein-Driven IGF-IR Signaling is a Therapeutic Target in Myxoid Liposarcoma. 23(20), 6227-6238. https://doi.org/10.1158/1078-0432.ccr-17-0130
Borjigin (2012) TLS-CHOP represses miR-486 expression, inducing upregulation of a metastasis regulator PAI-1 in human myxoid liposarcoma. 427(2), 355-360. https://doi.org/10.1016/j.bbrc.2012.09.063
Pilotti (1998) Limited Role of TP53 and TP53-Related Genes in Myxoid Liposarcoma. 84(5), 571-577. https://doi.org/10.1177/030089169808400512
Bode-Lesniewska (2007) Relevance of translocation type in myxoid liposarcoma and identification of a novel EWSR1‐DDIT3 fusion. 46, 961-971. https://doi.org/10.1002/gcc.20478
H. Zinszner, R. Albalat, D. Ron Ron, D A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP. 8, 2513-2526. https://doi.org/10.1101/gad.8.21
H. Kovar (2011) Dr. Jekyll and Mr. Hyde: The Two Faces of the FUS/EWS/TAF15 Protein Family.
Steffen Pahlich, Lilian Quero, Bernd Roschitzki, Ruzanna Leemann-Zakaryan, Heinz Gehring (2009) Analysis of Ewing Sarcoma (EWS)-Binding Proteins: Interaction with hnRNP M, U, and RNA-Helicases p68/72 within Protein−RNA Complexes. 8(10), 4455-4465. https://doi.org/10.1021/pr900235t
Kentaro Takahama, Katsuhito Kino, Shigeki Arai, Riki Kurokawa, Takanori Oyoshi (2011) Identification of Ewing's sarcoma protein as a G‐quadruplex DNA‐ and RNA‐binding protein. 278(6), 988-998. https://doi.org/10.1111/j.1742-4658.2011.08020.x
Dormann (2012) Arginine methylation next to the PY‐NLS modulates Transportin binding and nuclear import of FUS. 31(22), 4258-4275. https://doi.org/10.1038/emboj.2012.261
B. Waters, I. Panagopoulos, E. Allen (2000) Genetic characterization of angiomatoid fibrous histiocytoma identifies fusion of the FUS and ATF-1 genes induced by a chromosomal translocation involving bands 12q13 and 16p11. 121, 109-116.
Emad Raddaoui, Ludvik Donner, Ioannis Panagopoulos (2002) Fusion of the FUS and ATF1 Genes in a Large, Deep-Seated Angiomatoid Fibrous Histiocytoma. 11(3), 157-162. https://doi.org/10.1097/00019606-200209000-00006
H. Ichikawa, K. Shimizu, Y. Hayashi, M. Ohki An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation. 54, 2865-.
I. Panagopoulos (1994) Fusion of the FUS gene with ERG in acute myeloid leukemia with t(16;21) (p11;q22). 11(4), 256-. https://doi.org/10.1002/gcc.2870110408
C. Storlazzi (2003) Fusion of the FUS and BBF2H7 genes in low grade fibromyxoid sarcoma. 12(18), 2349-2358. https://doi.org/10.1093/hmg/ddg237
Huang (2015) Novel FUS‐KLF17 and EWSR1‐KLF17 fusions in myoepithelial tumors. 54(5), 267-275. https://doi.org/10.1002/gcc.22240
C. Turc-Carel et al Chromosomes in Ewing's sarcoma I An evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12). 32, 229-238. https://doi.org/10.1016/0165-
M. Ladanyi, W. Gerald (1994) Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor. 54, 2837-2840.
T. Kwiatkowski (2009) Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis. 323(5918), 1205-1208. https://doi.org/10.1126/science.1166066
Vance, an protein (2009) Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6. 323(5918), 1208-1211. https://doi.org/10.1126/science.1165942
Rademakers (2010) Fus gene mutations in familial and sporadic amyotrophic lateral sclerosis. 42(2), 170-176. https://doi.org/10.1002/mus.21665
Yang, L. localization (2015) Subcellular localization and RNAs determine FUS architecture in different cellular compartments. 24(18), 5174-5183. https://doi.org/10.1093/hmg/ddv239
J. Hemminger, O. Iwenofu A & Iwenofu, O H NY-ESO-1 is a sensitive and specific immunohistochemical marker for myxoid and round cell liposarcomas among related mesenchymal myxoid neoplasms. 26, 1204-1210. https://doi.org/10.1038/modpathol
E. Demicco (2011) G et al Involvement of the PI3K/Akt pathway in myxoid/round cell liposarcoma. 25, 212-221. https://doi.org/10.1038/modpathol.2011
Barretina (2010) Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy. 42(8), 715-721. https://doi.org/10.1038/ng.619
Oda (2005) Frequent alteration of p16 INK4a /p14 ARF and p53 pathways in the round cell component of myxoid/round cell liposarcoma: p53 gene alterations and reduced p14 ARF expression both correlate with poor prognosis. 207(4), 410-421. https://doi.org/10.1002/path.1848
R. Davidovic (2013) p14(ARF) methylation is a common event in the pathogenesis and progression of myxoid and pleomorphic liposarcoma. 30, 682. https://doi.org/10.1007/s12032-013-0682-9
Sievers (2006) Hypermethylation of the APC promoter but lack of APC mutations in myxoid/round‐cell liposarcoma. 119(10), 2347-2352. https://doi.org/10.1002/ijc.22117
Katharine Downes, John Goldblum, Elizabeth Montgomery, Cyril Fisher (2001) Pleomorphic Liposarcoma: A Clinicopathologic Analysis Of 19 Cases. 14(3), 179-184. https://doi.org/10.1038/modpathol.3880280
A. Oliveira, A. Nascimento (2001) Pleomorphic liposarcoma. 18, 274-285.
Nishio, J. Cytogenetics (2011) Contributions of Cytogenetics and Molecular Cytogenetics to the Diagnosis of Adipocytic Tumors. 2011, 9. https://doi.org/10.1155/2011/524067
Schmidt (2005) Gains of 13q are correlated with a poor prognosis in liposarcoma. 18(5), 638-644. https://doi.org/10.1038/modpathol.3800326
Rieker (2002) Distinct chromosomal imbalances in pleomorphic and in high‐grade dedifferentiated liposarcomas. 99(1), 68-73. https://doi.org/10.1002/ijc.10287
Idbaih (2005) Myxoid malignant fibrous histiocytoma and pleomorphic liposarcoma share very similar genomic imbalances. 85(2), 176-181. https://doi.org/10.1038/labinvest.3700202
F. Mertens (1998) Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP Study Group. 22(1), 16-. https://doi.org/10.1002/(sici)1098-2264(199805)22:1
J. Leighton, M. Hu, E. Sei, F. Meric-Bernstam, N. Navin (2021) Reconstructing mutational lineages in breast cancer by multi-patient-targeted single cell DNA sequencing. 468877.
A. Patel Science. 344, 1396-1401. https://doi.org/10.1126/science
J. Boen, J. Wagner, N. Di Nanni (2010) Inferring copy number variation from gene expression data: methods, comparisons, and applications to oncology. 463991.
Gao (2021) Delineating copy number and clonal substructure in human tumors from single-cell transcriptomes. 39(5), 599-608. https://doi.org/10.1038/s41587-020-00795-2
L. Jerby-Arnon et al Opposing immune and genetic mechanisms shape oncogenic programs in synovial sarcoma. 27, 289-300. https://doi.org/10.1038/s
M. Slyper et al A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors. 26, 792-802. https://doi.org/10.1038/s41591-
Rajbhandari (2019) Single cell analysis reveals immune cell-adipocyte crosstalk regulating the transcription of thermogenic adipocytes. 8. https://doi.org/10.7554/elife.49501
Sarvari (2021) Plasticity of Epididymal Adipose Tissue in Response to Diet-Induced Obesity at Single-Nucleus Resolution. 33, 437-453. https://doi.org/10.1016/j.cmet.2020.12.004
Sun (2020) snRNA-seq reveals a subpopulation of adipocytes that regulates thermogenesis. 587(7832), 98-102. https://doi.org/10.1038/s41586-020-2856-x
Emont (2022) A single-cell atlas of human and mouse white adipose tissue. 603(7903), 926-933. https://doi.org/10.1038/s41586-022-04518-2
C. Coombs, T. Dickherber, Crompton (2020) Chasing ctDNA in Patients With Sarcoma. 40, e351-e360.
Braig (2019) Genotyping of circulating cell‐free DNA enables noninvasive tumor detection in myxoid liposarcomas. 145(4), 1148-1161. https://doi.org/10.1002/ijc.32216
J. Przybyl Przybyl, J. et al. Detection of MDM2 amplification by shallow whole genome sequencing of cell-free DNA of patients with dedifferentiated liposarcoma. 17, 262272. https://doi.org/10.1371/journal.pone
D. Akolkar (2022) Evaluation of patient-specific cell free DNA assays for monitoring of minimal residual disease in solid tumors.
( https://clinicaltrials.gov/show/NCT02889978
Liu, M. Sensitive, specific detection (2020) Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. 31(6), 745-759. https://doi.org/10.1016/j.annonc.2020.02.011
Emily Keung, Neeta Somaiah (2019) Overview of liposarcomas and their genomic landscape. 3(8). https://doi.org/10.20517/jtgg.2019.03
Douglas Hanahan (2022) Hallmarks of Cancer: New Dimensions. 12(1), 31-46. https://doi.org/10.1158/2159-8290.cd-21-1059
Published
2022-09-05
Issue
Section
License
Copyright (c) 2022 Authors and Global Journals Private Limited

This work is licensed under a Creative Commons Attribution 4.0 International License.